1. Home
  2. CRDF vs CLAR Comparison

CRDF vs CLAR Comparison

Compare CRDF & CLAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRDF
  • CLAR
  • Stock Information
  • Founded
  • CRDF 1999
  • CLAR 1957
  • Country
  • CRDF United States
  • CLAR United States
  • Employees
  • CRDF N/A
  • CLAR N/A
  • Industry
  • CRDF Biotechnology: Biological Products (No Diagnostic Substances)
  • CLAR Recreational Games/Products/Toys
  • Sector
  • CRDF Health Care
  • CLAR Consumer Discretionary
  • Exchange
  • CRDF Nasdaq
  • CLAR Nasdaq
  • Market Cap
  • CRDF 169.6M
  • CLAR 150.4M
  • IPO Year
  • CRDF N/A
  • CLAR N/A
  • Fundamental
  • Price
  • CRDF $3.35
  • CLAR $3.14
  • Analyst Decision
  • CRDF Strong Buy
  • CLAR Strong Buy
  • Analyst Count
  • CRDF 4
  • CLAR 4
  • Target Price
  • CRDF $12.25
  • CLAR $5.50
  • AVG Volume (30 Days)
  • CRDF 874.0K
  • CLAR 158.2K
  • Earning Date
  • CRDF 05-08-2025
  • CLAR 05-08-2025
  • Dividend Yield
  • CRDF N/A
  • CLAR 3.15%
  • EPS Growth
  • CRDF N/A
  • CLAR N/A
  • EPS
  • CRDF N/A
  • CLAR N/A
  • Revenue
  • CRDF $587,000.00
  • CLAR $255,437,000.00
  • Revenue This Year
  • CRDF N/A
  • CLAR N/A
  • Revenue Next Year
  • CRDF N/A
  • CLAR $6.30
  • P/E Ratio
  • CRDF N/A
  • CLAR N/A
  • Revenue Growth
  • CRDF N/A
  • CLAR N/A
  • 52 Week Low
  • CRDF $2.01
  • CLAR $3.02
  • 52 Week High
  • CRDF $5.64
  • CLAR $7.13
  • Technical
  • Relative Strength Index (RSI)
  • CRDF 63.95
  • CLAR 42.62
  • Support Level
  • CRDF $2.81
  • CLAR $3.05
  • Resistance Level
  • CRDF $3.08
  • CLAR $3.18
  • Average True Range (ATR)
  • CRDF 0.20
  • CLAR 0.13
  • MACD
  • CRDF 0.08
  • CLAR 0.01
  • Stochastic Oscillator
  • CRDF 76.53
  • CLAR 24.49

About CRDF Cardiff Oncology Inc.

Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.

About CLAR Clarus Corporation

Clarus Corp is a designer, developer, manufacturer, and distributor of outdoor equipment and lifestyle products focused on the climb, ski, mountain, sport, and skincare markets. The company operates through the Outdoor segment, which includes Black Diamond Equipment and PIEPS, is a world-wide leader in designing, manufacturing, and marketing outdoor engineered equipment and apparel for climbing, mountaineering, trail running, backpacking, skiing, and a wide range of other year-round outdoor recreation activities. The Adventure segment, which includes Rhino-Rack, MAXTRAX and TRED, is a manufacturer of engineered automotive roof racks, trays, mounting systems, luggage boxes, carriers, recovery boards and accessories in Australia and New Zealand and United States.

Share on Social Networks: